- Home
- VERA
as 10-24-2025 3:53pm EST
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
| Founded: | 2016 | Country: | United States |
| Employees: | N/A | City: | BRISBANE |
| Market Cap: | 1.7B | IPO Year: | 2021 |
| Target Price: | $62.25 | AVG Volume (30 days): | 1.2M |
| Analyst Decision: | Buy | Number of Analysts: | 9 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.59 | EPS Growth: | N/A |
| 52 Week Low/High: | $18.53 - $51.61 | Next Earning Date: | 11-07-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Vera Therapeutics Inc. News
VERA Breaking Stock News: Dive into VERA Ticker-Specific Updates for Smart Investing
MT Newswires
4 months ago
Vera Therapeutics Insider Bought Shares Worth $5,277,311, According to a Recent SEC Filing
GlobeNewswire
5 months ago
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
MT Newswires
5 months ago
Wedbush Cuts Price Target on Vera Therapeutics to $23 From $32, Keeps Neutral Rating
Barrons.com
5 months ago
Biotech Stock Vera Is Slumping After Monster Gain
MT Newswires
5 months ago
Top Premarket Decliners
Investing.com
5 months ago
Vera Therapeutics stock sinks following competitor’s successful trial
GlobeNewswire
5 months ago
Vera Therapeutics to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
MT Newswires
5 months ago
Vera Therapeutics Receives Up to $500 Million in New Credit Facility
Compare VERA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "VERA Vera Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.